Abstract
Objective: To study the effect of Kanglaite (KLT) in treating pulmonary carcinoma (PC) patients with Lung-Qi Deficiency and immunologic inadequacy (LDII) after pneumonectomy.Methods: Thirtysix patients of PC-LDII were treated with KLT and the lymphocyte subset was examined before and after treatment.Results: The markedly effective rate of treatment was 50.0% and the total effective rate 66.7%. Immunological examination showed that the lymphocyte subset of patients tended to get normal and the difference between pre-treatment and post-treatment was significant.Conclusion: KLT could improve the symptom of Lung-Qi Deficiency and markedly strengthen the immune function of PC patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
1986, 6(10): 598.
1 1995: 19–21, 499–500.
1 1993: 1–2, 91–94.
1 1984: 99–105.
1 1980: 204–205.
1 1980: 146–147.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, X., Ma, C. & Wang, X. Clinical observation on effect of Kanglaite (
) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy) in treating pulmonary carcinoma patients with Lung-Qi Deficiency and immunologic inadequacy after pneumonectomy.
CJIM 5, 105–107 (1999). https://doi.org/10.1007/BF02934653
Issue Date:
DOI: https://doi.org/10.1007/BF02934653